Recon Strategy
Contact

Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

Sector
All
NEJM opinion

Preclinical Licensing Deals Realized Value

  • Biopharma
Download a PDF of this paper here.   M&A deals in biopharma o…

Read more